Personalized medicine promises to deliver the right treatment to the right patient at the right price. Yet the highly individualized nature of personalized medicine — tailoring treatment and dosing to each person’s unique lifestyle, environment (exposures) and genetics (genetic profile)—and its potential costs, raises questions regarding the applicability of personalized medicine on a population-wide basis. And, more specifically, whether personalized medicine, and the massive federal Precision Medicine Initiative and All of Us research program, are likely to have a significant impact on the health of the American public. Join us for this full-day symposium at which nationally-renowned experts in personalized medicine, genomics, epidemiology, health disparities, regulatory science, and bioethics will wrestle with the question whether and how personalized medicine can improve population health.
The conference will take place on March 16, 2018 at the Health Sciences Education Building, 1730. It will be presented by University of Utah Health, University of Utah, the S.J. Quinney College of Law, Center for Law and Biomedical Sciences, Huntsman Cancer Institute, and the School of Medicine. Learn more about the conference.